President Donald Trump signs an executive order that expands federal research into psychedelic drugs to treat patients, and veterans in particular, suffering from PTSD and traumatic brain injuries, in the Oval Office at the White House on April 18, 2026.
Keystone
Switzerland is the only country in Europe offering psychedelic treatments, but access remains extremely limited for patients. US support for novel treatments means things could change, analyses Swissinfo healthcare reporter Aylin Elçi.
Generated with artificial intelligence.
This content was published on
